Pricing Log in Create free account

Freenome, Inc (FRNM) vs OPKO Health, Inc. (OPK)

Freenome, Inc and OPKO Health, Inc. are both Diagnostics & Research companies. OPKO Health, Inc. is the larger, with a market value of $1.3B against $1.1B — 1.2× the size. Freenome, Inc has the higher net margin (0.00% vs −29.5%) and the higher return on invested capital (0.00% vs −6.72%). Across the 12 metrics below, Freenome, Inc leads on 11 and OPKO Health, Inc. on 1.

Valuation

Metric FRNM OPK Diagnostics & Research median
P/E n/m n/m 34.52
P/S n/m 2.60 4.24
P/B n/m 1.17 3.42
Price to free cash flow n/m n/m 33.51
EV/EBITDA n/m n/m 23.44
EV/Sales n/m 2.77 5.18
Earnings yield (2.98%) (10.86%) (1.50%)
Free cash flow yield (3.55%) (11.10%) 0.00%

Profitability

Metric FRNM OPK Diagnostics & Research median
Gross margin — 46.22% 48.32%
Operating margin 0.00% (25.46%) (5.68%)
Net margin 0.00% (29.51%) (4.10%)
Free cash flow margin 0.00% (26.91%) 0.00%
Return on equity 17.81% (12.23%) 0.00%
Return on assets (0.86%) (7.64%) (6.05%)
Return on invested capital 0.00% (6.72%) 0.00%

Growth

Metric FRNM OPK Diagnostics & Research median
Revenue growth (TTM) — (21.87%) 8.99%
EPS growth (last fiscal year) (58.34%) (275.00%) 20.36%
Revenue growth, 5-year CAGR — (15.82%) 7.30%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric FRNM OPK Diagnostics & Research median
Debt to equity 0.00 0.41 0.01
Current ratio 0.20 4.97 2.27
Net debt to EBITDA 0.29 1.33 0.68

Dividend

Metric FRNM OPK Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric FRNM OPK Diagnostics & Research median
Market cap 1.12b 1.31b 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack